Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and tolerability of Bilastine 20 mg,
compared to Cetirizine and placebo for the treatment of seasonal allergic rhinitis.